NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
April 6, 2004 • Volume 1 / Number 14 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

The information and links on this page are no longer being updated and are provided for reference purposes only.


Three Top NCI Positions Filled
NCI Director Dr. Andrew C. von Eschenbach recently announced three new appointments - a new director for the Division of Cancer Treatment and Diagnosis (DCTD) and two new deputy directors within his office.

As the new DCTD director, Dr. James H. Doroshow fills a position vacant since 2001. He comes to NCI from Los Angeles, where for 20 years he served as both chair of the Department of Medical Oncology and Therapeutics Research and as associate director for clinical research at the City of Hope Comprehensive Cancer Center. In addition to his division responsibilities, Dr. Doroshow will lead NCI's Clinical Trials Working Group.

In the director's office, Dr. Karen Antman will lead strategic scientific efforts in her new role as deputy director for Translational and Clinical Sciences. She will direct a broad national research program that includes the Cancer Centers Program, the Specialized Programs of Research Excellence, and other translational programs. Dr. Antman had been director of the Columbia University's Herbert Irving Comprehensive Cancer Center and chief of the Division of Medical Oncology.

As reported in the Feb. 10 NCI Cancer Bulletin, Dr. Mark Clanton was recently named the new deputy director for Cancer Care and Delivery Systems at NCI. With a strong background in managed care and health plan administration, Dr. Clanton will bring his expertise to bear on expanding and enhancing NCI's research portfolio to have a greater impact on cancer care delivery.

Telephone Education Workshop on Cancer Survivorship
On March 10, NCI's Office of Cancer Survivorship and Office of Education and Special Initiatives kicked off the Second Annual Cancer Survivorship Series, "Living With, Through & Beyond Cancer." More than 1,300 participants from around the world phoned in to hear expert speakers discuss "Living with Uncertainty" and the feelings that accompany the period following cancer treatment. The program, a collaboration with CancerCare, the Intercultural Cancer Council, Living Beyond Breast Cancer, and the National Coalition for Cancer Survivorship, is co-funded by the Lance Armstrong Foundation and NCI. The second survivorship education workshop, "Talking About Cancer with Children of All Ages," is scheduled for April 14. The topic for the third and final installment on May 19 will be "Turning Research into Action." Calls take place on Wednesdays from 1:00 to 2:00 p.m. Eastern Time, and participants can register online at or call Cancer Care at 1-800-813-HOPE for more information.

NCI Director Receives Cancer Public Service Award
On April 2, NCI Director Dr. Andrew C. von Eschenbach received the first Distinguished Cancer Public Service Award from the George Washington University Cancer Institute. The award is presented to an individual who has "provided outstanding public leadership in cancer health care and public policy."

Other awards from the GW Cancer Institute included the Cancer Advocacy Achievement Award to Dr. Ellen Sigal, Chair, Friends of Cancer Research; the Cancer Compassion Award to Zora Brown, Founder and Chair of the Cancer Awareness Program Services and Breast Cancer Resource Committee; and the Celebration of Life Award to Lance Armstrong, Tour de France champion and founder of the Lance Armstrong Foundation.

Constance PercyConstance Percy Dies at 89
Former NCI statistician Constance Percy died of lung cancer on March 24 at her home in Rockville, Md. Ms. Percy was with NCI for 31 years and was internationally recognized for her work in cancer nomenclature and classification standards. She was instrumental in the development of NCI's Surveillance, Epidemiology and End Results Program. She also contributed to the establishment of international cancer nomenclature with the International Classification of Diseases for Oncology. Before joining NCI in 1970, Ms. Percy worked for the American Cancer Society for 22 years. She was part of the research team that produced the seminal study linking smoking with lung cancer and heart disease; she was an advocate for tobacco control. Ms. Percy was a chemistry graduate of Cornell University and received a master's degree in public health from Columbia University. She is survived by a sister, two daughters, and two granddaughters.